Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TCT 2025

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 1159: Deep Learning-BasedDetection and SegmentationofSubclinicalLeafletThrombosison 4DCT After TAVI

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 1693: STEMI Due to Left Main Occlusion in a Young Patient: Is Stenting Always Necessary? An Alternative Approach Using Drug-Coated Balloon Therapy

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2025

Presentation TCT 2025

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

Presentation TCT 2024

TCT 1382: Inferior STEMI Due to Late Coronary Occlusion in a Degenerated TAVR

Presenter: Victor Alfonso Jimenez Diaz

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2024

Presentation TCT 2022

TCT 373: Using deep learning for TAVI characterization in angiographic sequences for extracting radiomic biomarkers of prosthesis deterioration

Presenter: Victor Alfonso Jimenez Diaz

September 19, 2022

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation CRT 2018

Assessment of Platelet Reactivity after Transcatheter Aortic Valve Implantation: REAC TAVI trial

Presenter: Victor Alfonso Jimenez Diaz

March 05, 2018

Advertisement

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

TCT 1159: Deep Learning-BasedDetection and SegmentationofSubclinicalLeafletThrombosison 4DCT After TAVI

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

TCT 1693: STEMI Due to Left Main Occlusion in a Young Patient: Is Stenting Always Necessary? An Alternative Approach Using Drug-Coated Balloon Therapy

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

TCT 1382: Inferior STEMI Due to Late Coronary Occlusion in a Degenerated TAVR

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

TCT 373: Using deep learning for TAVI characterization in angiographic sequences for extracting radiomic biomarkers of prosthesis deterioration

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Assessment of Platelet Reactivity after Transcatheter Aortic Valve Implantation: REAC TAVI trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content